Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
bone marrow stem cells
Biotech
Cash-strapped Gamida steps up search for strategic alternatives
Despite finally getting an off-the-shelf stem cell transplant to market last year, Gamida Cell is continuing to search for a financial life raft.
James Waldron
Jan 29, 2024 8:41am
FDA extends review of Gamida Cell's approval by 3 months
Nov 22, 2022 10:55am
Magenta hopes to infuse resiliency through job cuts, R&D trim
Apr 14, 2022 10:55am
J&J, Vor ally to assess bispecific and stem cell therapy in AML
Jul 9, 2021 7:50am
Harvard stem cell research lead Hoggatt joins Moderna
Mar 5, 2021 4:21am
Magenta CSO Michael Cooke jumps to IFM Therapeutics
Jan 7, 2020 10:19am
